Cancer Treatment

Independent UK says medical supervision as the first treatment shown to help people is the deadliest form of skin cancer is too expensive to be used by the British health system, as a critic of a recommendation of sentence death is possible.

The drug, Bristol-Meyers Squibb Yervoy offered little hope for people with advanced cancer of the skin, although a recent study showed that only worked in a limited segment of patients studied, and only lived four months of than patients treated with older drugs.

The National Institute for Clinical Excellence. "I could not use a cost to be considered a" month of Nice or recommended Friday that, at a price of 80,000 pounds ($ 126,600) insurance Yervoy final decision is scheduled for public hearing.

In Britain, for most drugs that are paid by the government, provided they are recommended by financial watchdog. The agency often denied expensive drugs, as recently warned against new treatments for prostate cancer, breast cancer and multiple sclerosis, if patients and doctors are more and more protests against decisions.